Showing 1861-1870 of 5275 results for "".
How Viable is Pay-for-Performance in Dermatology?
https://practicaldermatology.com/topics/general-topics/PD0509_03-php/22825/Though Pay-for-Performance has affected primary care medicine for years, it has only recently expanded into specialized medicine. Experts discuss its eventual impact on dermatology.Hyperpigmentation Treatment Pearls and More
https://practicaldermatology.com/conferences/cosmetic-surgery-forum-2022/hyperpigmentation-treatment-pearls-and-more/20161/Corey Hartman, MD shares his approach to treating periorbital hyperpigmentation in darker skin types, including using fillers to replace volume, give lift, and replace loss of bony structures and fat pads. Dr. Hartman also discusses the benefits of Cynosure’s PicoSure device to correct hyperpigmentaDupixent for Adolescents priority review, Restylane Lyft via cannulas, Hyperhidrosis Awareness
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-dupixent-for-adolescents-priority-review-restylane-lyft-via-cannulas-hyperhidrosis-awareness/18215/FDA grants priority review for Sanofi's and Regeneron's sBLA for Dupixent (dupilumab) for adolescents. Galderma's Restylane Lyft is approved for use with a small, blunt-tip cannula for cheek augmentation and the correction of age-related midface contour deficiencies in patients over the age of 21. TMedical Derm at Summer AAD; Novel Drugs, Acne at Derm 2018
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-medical-derm-at-summer-aad-novel-drugs-acne-at-derm-2018/18244/The Summer meeting of the American Academy of Dermatology (AAD) gathers members for updates on medical and aesthetic advancements. This year, topics included advanced therapeutics, skin cancer, and skin of color. DERM 2018 provides an opportunity for nurse practitioners and physician assistants in dIndiana Gets SUNucated, Dr. Joel Cohen Honored, Rosacea Awareness
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-indiana-gets-sunucated-dr-joel-cohen-honored-rosacea-awareness/18317/Indiana is the first state in 2018 to give children broader access to sunscreen at school through the SUNucation Initiative. The Indiana Academy of Dermatology, with a grant from the American Society for Dermatologic Surgery Association, helped successfully pass the legislation. Joel L. Cohen, MD ofAAD SkinSerious Campaign, Meeting Highlights; Galderma Partners with Modernizing Medicine
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-aad-skinserious-campaign-meeting-highlights-galderma-partners-with-modernizing-medicine/18515/The American Academy of Dermatology's new SkinSerious campaign is raising awareness about skin disease and the specialty. The Skin Serious initiative kicked off at the AAD Annual Meeting in Orlando this month. New research presented at this year's meeting focused on skin disease prevention and treatStarting a Systemic Therapy in Atopic Dermatitis or Psoriasis
https://practicaldermatology.com/series/pa-perspectives/Starting-a-Systemic-Therapy-in-Atopic-Dermatitis-or-Psoriasis/26644/In this video, Andrew Mastro, MS, PA-C, a board-certified physician assistant (PA) at the Illinois Dermatology Institute in Chicago, discusses how to talk to patients about starting a systemic therapy in atopic dermatitis or psoriasis; how to keep the conversation to 7 minutes; and the importance ofChitotriosidase: Providing Confirmation of Sarcoidosis When ACE Fails
https://practicaldermatology.com/topics/clinical-case-reports/chitotriosidase-providing-confirmation-of-sarcoidosis-when-ace-fails/26642/Chitotriosidase: Providing Confirmation of Sarcoidosis When ACE FailsDermWireTV: Zoryve Approved; New SDPA President; Project Determi-Nation; Stelara for Pediatric PsA
https://practicaldermatology.com/topics/psoriasis/dermwiretv-zoryve-approved-new-sdpa-president-project-determi-nation-stelara-for-pediatric-psa/20115/FDA has approved Zoryve from Arcutis Biotherapeutics for the treatment of plaque psoriasis, including intertriginous areas, in patients 12 years of age or older. The novel formulation of roflumilast cream 0.3% is indicated for once-daily application. Stelara (ustekinumab) from Janssen is now approveDermWireTV: Vtama Approved; Monkey Pox; AbbVie Scholarship; LRP Pride in Dermatology
https://practicaldermatology.com/topics/psoriasis/dermwiretv-vtama-approved-monkey-pox-abbvie-scholarship-lrp-pride-in-dermatology/20097/Vtama (tapinarof) cream 1% from Dermavant is approved for the treatment of psoriasis in adults. Tapinarof is an aryl hydrocarbon receptor agonist. As a public health service, VisualDx is offering pictures of monkey pox and disease information to support clinical decision-making. Forty-five scholarsh